| Corborn's Pharmacy 2034 | |
| 1106 8th St Sw, Pipestone, Minnesota 56164 | |
| (507) 825-0091 |
| Name | Corborn's Pharmacy 2034 |
|---|---|
| Organization Name | Coborns Inc |
| Location | 1106 8th St Sw, Pipestone, Minnesota 56164 |
| Type | DME Supplier - Customized Equipment |
| Phone | (507) 825-0091 |
| Participate in Medicare | Medicare enrolled and may accept medicare assignment. Please check with the supplier if they accept medicare-approved amount before you get your prescription drugs, equipment or supplies from this supplier. |
News Archive
Covidien, a leading global provider of healthcare products, today announced that it has completed the previously announced sale of its Specialty Chemicals business to an affiliate of New Mountain Capital, L.L.C. for a cash purchase price of approximately $280 million.
CombinatoRx, Incorporated today announced that it has received a milestone payment from Fovea Pharmaceuticals, a division of Sanofi Aventis, relating to Fovea's initiation of Phase 2b clinical testing of PrednisporinTM (FOV1101) in subjects with persistent allergic conjunctivitis. Prednisporin™ is a CombinatoRx-derived combination drug candidate that was exclusively licensed to Fovea by CombinatoRx.
Mast Therapeutics, Inc. today announced that two posters for its lead product candidate, MST-188, were presented at the 7th Annual Sickle Cell Disease Research & Educational Symposium, currently underway in Miami.
A study published today in the Journal of Neuroscience led by Yongjie Yang of Tufts University School of Medicine identifies an astroglial trigger mechanism as contributing to symptoms of fragile X syndrome in mice.
Health experts from all over the world are to decide this week whether to hold on to the last remaining stockpiles of smallpox, one of the deadliest diseases in history – or to proceed with their destruction.
› Verified 7 days ago
| NPI Number | 1982968640 |
| Organization Name | COBORNS INC |
| Doing Business As | COBORN'S PHARMACY #2034 |
| Type | DME Supplier - Customized Equipment |
| Address | 1106 8th St Sw, Pipestone, MN 56164 |
| Phone Number | 507-825-0091 |
News Archive
Covidien, a leading global provider of healthcare products, today announced that it has completed the previously announced sale of its Specialty Chemicals business to an affiliate of New Mountain Capital, L.L.C. for a cash purchase price of approximately $280 million.
CombinatoRx, Incorporated today announced that it has received a milestone payment from Fovea Pharmaceuticals, a division of Sanofi Aventis, relating to Fovea's initiation of Phase 2b clinical testing of PrednisporinTM (FOV1101) in subjects with persistent allergic conjunctivitis. Prednisporin™ is a CombinatoRx-derived combination drug candidate that was exclusively licensed to Fovea by CombinatoRx.
Mast Therapeutics, Inc. today announced that two posters for its lead product candidate, MST-188, were presented at the 7th Annual Sickle Cell Disease Research & Educational Symposium, currently underway in Miami.
A study published today in the Journal of Neuroscience led by Yongjie Yang of Tufts University School of Medicine identifies an astroglial trigger mechanism as contributing to symptoms of fragile X syndrome in mice.
Health experts from all over the world are to decide this week whether to hold on to the last remaining stockpiles of smallpox, one of the deadliest diseases in history – or to proceed with their destruction.
› Verified 7 days ago
News Archive
Covidien, a leading global provider of healthcare products, today announced that it has completed the previously announced sale of its Specialty Chemicals business to an affiliate of New Mountain Capital, L.L.C. for a cash purchase price of approximately $280 million.
CombinatoRx, Incorporated today announced that it has received a milestone payment from Fovea Pharmaceuticals, a division of Sanofi Aventis, relating to Fovea's initiation of Phase 2b clinical testing of PrednisporinTM (FOV1101) in subjects with persistent allergic conjunctivitis. Prednisporin™ is a CombinatoRx-derived combination drug candidate that was exclusively licensed to Fovea by CombinatoRx.
Mast Therapeutics, Inc. today announced that two posters for its lead product candidate, MST-188, were presented at the 7th Annual Sickle Cell Disease Research & Educational Symposium, currently underway in Miami.
A study published today in the Journal of Neuroscience led by Yongjie Yang of Tufts University School of Medicine identifies an astroglial trigger mechanism as contributing to symptoms of fragile X syndrome in mice.
Health experts from all over the world are to decide this week whether to hold on to the last remaining stockpiles of smallpox, one of the deadliest diseases in history – or to proceed with their destruction.
› Verified 7 days ago
A And S Drugs Type: Pharmacy Location: 101 West Main Street, Pipestone, Minnesota 56164 Phone: (507) 825-3100 | |
Corborn's Pharmacy 2034 Type: DME Supplier - Customized Equipment Location: 1106 8th St Sw, Pipestone, Minnesota 56164 Phone: (507) 825-0091 | |
Dr Douglas J Vermeer Od Type: Medicare Supplier Location: 105 W Main St, Pipestone, Minnesota 56164 Phone: (507) 825-5263 | |
Henriksen Paul A O Type: Durable Medical Equipment & Medical Supplies Supplier Location: 212 W Main St, Pipestone, Minnesota 56164 Phone: (507) 825-5444 |